Ligand Pharmaceuticals (LGND) Tax Rate Growth (3y) (2013 - 2026)
Ligand Pharmaceuticals (LGND) Tax Rate Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,102.16 Bn | 67,101.87 Bn | - |
| 2 | Nanobiotix | 1,908.96 Bn | 1,908.90 Bn | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - |
| 4 | BeOne Medicines | 474.03 Bn | 469.24 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.13 Bn | 114.88 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.09 Bn | 61.34 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.34 Bn | 62.34 Bn | - |
| 8 | Argenx Se | 55.96 Bn | 50.77 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.53 Bn | 34.52 Bn | 959.66 Mn |
| 10 | Ligand Pharmaceuticals | 5.87 Bn | 5.09 Bn | 48.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2,352.00 |
| Dec 31, 2025 | -13,908.00 |
| Sep 30, 2025 | -502.00 |
| Jun 30, 2025 | 10,228.00 |
| Mar 31, 2025 | 5,680.00 |
| Dec 31, 2024 | -213.00 |
| Sep 30, 2024 | -2,321.00 |
| Jun 30, 2024 | 1,288.00 |
| Mar 31, 2024 | 23,819.00 |
| Dec 31, 2023 | 935.00 |
| Sep 30, 2023 | -2,689.00 |
| Jun 30, 2023 | 633.00 |
| Mar 31, 2023 | 81.00 |
| Dec 31, 2022 | 15,030.00 |
| Sep 30, 2022 | -132.00 |
| Jun 30, 2022 | -6,549.00 |
| Mar 31, 2022 | -6,232.00 |
| Dec 31, 2021 | -236.00 |
| Sep 30, 2021 | -491.00 |
| Jun 30, 2021 | -1,572.00 |